Related Experiment Video
Updated: Jul 20, 2026

An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells
Published on: September 12, 2019
Cervical cancer
1Section of Gynecologic Oncology, University Hospitals of Cleveland, 11100 Euclid Avenue, Cleveland, OH 44106, USA. steven.waggoner@uhhs.com <steven.waggoner@uhhs.com>
Cervical cancer affects nearly 500,000 women globally each year, particularly in regions lacking screening. While early stages are curable, treatment challenges persist for advanced and recurrent disease, impacting quality of life.
Area of Science:
- Oncology
- Public Health
- Gynecology
Background:
- Cervical cancer is a significant global health issue, with high incidence in developing nations lacking screening.
- Key risk factors include human papillomavirus infection, smoking, and compromised immune systems.
- While early-stage cervical cancer is often curable, treatment can lead to long-term morbidity.
Purpose of the Study:
- To review the current standard of care for cervical cancer, including chemoradiotherapy for locally advanced disease.
- To assess the applicability of established treatments in resource-limited settings.
- To highlight concerns regarding treatment approaches for localized tumors and the ineffectiveness of treating recurrent cervical cancer.
Main Methods:
- Review of randomized clinical trials on chemoradiotherapy for locally advanced cervical cancer.
- Analysis of treatment modalities for localized (stage IB) cervical cancer, including surgery and radiotherapy.
- Evaluation of treatment outcomes for recurrent cervical cancer.
Main Results:
- Chemoradiotherapy is the standard of care for locally advanced cervical cancer, but its use in less developed countries is not well-established.
- Treatment for localized tumors often involves surgery and radiotherapy, with ongoing concerns about associated morbidity.
- Effective treatments for recurrent cervical cancer are limited.
Conclusions:
- The standard of care for cervical cancer requires adaptation for resource-limited settings.
- Minimizing treatment morbidity and improving quality of life are crucial considerations for both primary and recurrent cervical cancer management.
- Further research is needed to optimize treatment strategies and address disparities in care.
Related Concept Videos
Cancer
What is Cancer?
Although people have known about cancer for centuries, it was only in 1761 that Giovanni Morgagni of Padua performed a detailed autopsy of patients who died from...
What is Cancer?
Although people have known about cancer for centuries, it was only in 1761 that Giovanni Morgagni of Padua performed a detailed autopsy of patients who died from...
Uterus and Cervix
The uterus is securely anchored within the pelvic cavity by paired broad ligaments on either side. It is further stabilized by three pairs of...
Disorders of the Female Reproductive System
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...

